Vestipitant
- Generic Name
- Vestipitant
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H24F7N3O
- CAS Number
- 334476-46-9
- Unique Ingredient Identifier
- S052TOI9BI
- Background
Vestipitant has been investigated for the treatment of Tinnitus.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-01-10
- Last Posted Date
- 2012-10-02
- Lead Sponsor
- Accenture
- Target Recruit Count
- 131
- Registration Number
- NCT01507194
- Locations
- 🇺🇸
Visions Clinical Research, Boynton Beach, Florida, United States
🇺🇸CAP Anesthesia (St. Elizabeth's Medical Center), Boston, Massachusetts, United States
🇺🇸University of Pittsburg, Pittsburgh, Pennsylvania, United States
Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-31
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 26
- Registration Number
- NCT00394056
- Locations
- 🇬🇧
GSK Investigational Site, Cambridge, Cambridgeshire, United Kingdom
PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-06-23
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 72
- Registration Number
- NCT00343707
- Locations
- 🇸🇪
GSK Investigational Site, Uppsala, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath